Clinical Trials Directory

Trials / Completed

CompletedNCT00000817

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
260 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

To evaluate the separate and combined efficacy of a standardized acupuncture regimen and amitriptyline on the relief of pain due to peripheral neuropathy and on the quality of life of HIV-infected patients. Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.

Detailed description

Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection. Patients are randomized to receive either standardized point acupuncture or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks. Acupuncture points are located on the lower leg. Patients are evaluated at weeks 6 and 14 and are asked to keep a daily pain diary.

Conditions

Interventions

TypeNameDescription
DRUGAmitriptyline hydrochloride75 mg oral tablet taken daily
DRUGAmitriptyline hydrochloride placeboOral placebo tablet taken daily
PROCEDUREPoint acupunctureStandardized or alternate acupuncture procedure

Timeline

Start date
1994-11-01
Completion
1997-05-01
First posted
2001-08-31
Last updated
2021-11-03

Locations

11 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00000817. Inclusion in this directory is not an endorsement.